This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Ocugen Inc. (OCGN) slipped 2.35% to $1.46 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&amp;P 500 Index rising 1.46% to 7,365.12 and the Dow Jones Industrial Average rising 1.24% to 49,910.59.
This was the stock's second consecutive day of losses.
Ocugen Inc. closed 46.61% below its 52-week high of $2.73, which the company reached on March 17th.
Trading volume (15.4 M) eclipsed its 50-day average volume of 9.4 M.
Data source: Dow Jones Market Data, FactSet. Data compiled May 6, 2026.
This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
05-06-26 1727ET

OCGN

SBIO

LABU

IBBQ

Shares of Ocugen Inc. (OCGN) fell 2.35% to $1.46 on Wednesday, underperforming the market as the S&P 500 rose 1.46% and the Dow Jones increased by 1.24%. This marks the second consecutive day of losses for Ocugen, which is now 46.61% below its 52-week high of $2.73 reached on March 17. Trading volume was 15.4 million, surpassing the 50-day average of 9.4 million.

MarketWatch Automated

Ocugen

VanEck Biotech ETF

First Trust NYSE Arca Biotech Index Fd

Proshares Ultra Nasdaq Biotech

Invesco Biotechnology & Genome ETF

SPDR S&P Biotech

iShares Biotechnology ETF

ALPS Medical Breakthrough

Direxion S&P Biotech Bull 3X

Invesco Nasdaq Biotechnology ETF

S&P 500

Dow Jones Industrial Average

Factset Research

Ocugen Inc. Stock Falls Wednesday, Underperforms Market